Trial Details

Authorised
Basic Information
Clinical ID c2773
Identifier EUCTR2017-003228-54-ES
Trial Title A Phase IIa (proof of concept), randomized, double blind, placebo controlled, multicenter clinical trial to evaluate the safety and efficacy of oral treatment with PBF-677 in patients with mild to moderate ulcerative colitis.
Trial URL Visit Original Page
Study Information
Study Results

No results available
Conditions Inflammatory Bowel disease, mild to moderate Ulcerative Colitis;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Interventions Product Code: PBF-677 Pharmaceutical Form: Capsule, hard INN or Proposed INN: PBF-677 Current Sponsor code: PBF-677 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 200- Pharmaceutical form of the placebo: Capsule, hard Route of administration of the placebo: Oral use
Participant Information
Sponsor PaloBiofarma S.L.
City -
Country/Region Spain
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement -
Study Design
Study Type Interventional clinical trial of medicinal product
Phase PHASE2
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -